Leighton Holdings has received a contract to build the first proton cancer therapy centre in Saudi Arabia. The contract is worth US$74 million.
Middle Eastern joint venture of Leighton, Habtoor Leighton Group received the contract to take up the construction of the centre at King Fahad Medical City in Riyadh in a 50/50 joint venture with Al Latifia Trading and Contracting.
Within a month, this contract is the second healthcare deal won by Habtoor Leighton in Saudi Arabia. Earlier in September, the company had received a US$316 million deal with Al Latifia Trading and Contracting to construct new medical centres.
According to Jose Antonio Lopez-Monis, Habtoor Leighton\'s new managing director, the proton therapy centre would provide access to the best cancer treatment technology in the world to Saudi Arabia as well as neighbouring Gulf states.
Middle Eastern joint venture of Leighton, Habtoor Leighton Group received the contract to take up the construction of the centre at King Fahad Medical City in Riyadh in a 50/50 joint venture with Al Latifia Trading and Contracting.
Within a month, this contract is the second healthcare deal won by Habtoor Leighton in Saudi Arabia. Earlier in September, the company had received a US$316 million deal with Al Latifia Trading and Contracting to construct new medical centres.
According to Jose Antonio Lopez-Monis, Habtoor Leighton\'s new managing director, the proton therapy centre would provide access to the best cancer treatment technology in the world to Saudi Arabia as well as neighbouring Gulf states.